BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 11, 2025
Home » Newsletters » BioWorld

BioWorld

March 9, 2015

View Archived Issues

BioWorld stock report for public biotechnology companies

Read More

BioWorld Stock Index 2015

Read More

Nasdaq Stock Index 2015

Read More

Money raised by biotech Jan. 1 - March 5, 2015

Read More

Money raised by biotech in 2015 vs. 2014

Read More

Milestone payments from corporate partners: February 2015

Read More

Venture capital & other investments in private biotechnology companies: February 2015

Read More

2015 top financings of private companies

Read More

Other financings of public biotechnology companies: February 2015

Read More

2015 top private financings of public companies

Read More

Secondary trading environment critical for small businesses

Emerging companies are considered to be the drivers of U.S. economic activity, innovation and job creation. Their ability to survive and prosper depends on ready access to capital, particularly in the private markets. The SEC Advisory Committee on Small and Emerging Companies met to discuss ways in which the secondary trading environment for the securities of small businesses can be improved. It is an issue that needs to be solved quickly in view of a projected increase in those securities. Read More

Week in review

Read More

Word on the street

Read More

Week in Washington

Read More

Biotech money raised by month in 2015

Read More

Public financing of biotechnology companies: Commenced trading in February 2015

Read More

Public financing of biotechnology companies: Filed and pending IPOs

Read More

Developing targeted therapies for head and neck cancers

The American Society of Clinical Oncology (ASCO) estimates that cancers of the head and neck, a diverse group of tumors that arise in the mouth, nose, throat and larynx, account for about 3 percent of all malignancies in the U.S. Most are squamous cell carcinomas that begin in the flat, squamous cells that make up the epithelium of the head and neck. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 10, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 10, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • RFK at Senate HELP meeting 5-14

    US lawmakers demand that Kennedy be held accountable

    BioWorld
    As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
  • Illustration of head with maze that is missing parts

    CTAD 2025: The challenges of combination therapies for dementia

    BioWorld Science
    At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing